Research Use Only. Products are not for human consumption, clinical use, or veterinary administration. RUO policy
5 mg - Research material
Metabolic Research

Tirzepatide

Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.

Research price
$149
5 mg vial - Lyophilized powder
Research Use Only. This material is not for human consumption, injection, clinical use, or veterinary administration. Sold only to qualified researchers and institutions. RUO policy.
Specifications
Size5 mg
FormLyophilized powder
Purity / documentationLot-specific Certificate of Analysis available on request
CAS2023788-19-2
Molecular weight4813.5 g/mol (reference)
Sequence / identityDual GIP / GLP-1 receptor agonist peptide (research material)
Intended useIn vitro laboratory research only (RUO)

Research context

Tirzepatide is supplied strictly for research use in metabolic and dual-agonist pathway models. Specs are lot-dependent; request CoA documentation for analytical details. Not intended for human consumption or clinical use.

Research focus areas
Dual agonist research GIP/GLP-1 pathways Metabolic model systems

Content is for scientific reference only and does not constitute medical advice or instructions for human use.

Related research materials

5 mg
CoA on request
Metabolic Research

Semaglutide

Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.

$129
View
5 mg
CoA on request
Metabolic Research

Retatrutide

Investigational triple-agonist peptide for laboratory metabolic pathway research in model systems.

$179
View